Risk factors for colon cancer in northeastern thailand: Interaction of MTHFR codon 677 and 1298 genotypes with environmental factors

Journal of Epidemiology

Volumn 20, Issue 4, 2010, Pages 329-338

  Promthet, Supannee Sriamporn ^a   Pientong, Chamsai ^a   Ekalaksananan, Tipaya ^a   Wiangnon, Surapon ^a   Poomphakwaen, Kirati ^b   Songserm, Nopparat ^a,c   Chopjitt, Peechanika ^a   Moore, Malcolm A ^d   Tokudome, Shinkan ^e  

^a KHON KAEN UNIVERSITY   (Thailand)

^b LOEI RAJABHAT UNIVERSITY   (Thailand)

^c UBON RATCHATHANI RAJABHAT UNIVERSITY   (Thailand)

^d UICC Asian Regional Office for Cancer Control   (Japan)

^e NATIONAL INSTITUTE OF HEALTH AND NUTRITION   (Japan)

Author keywords

Colon cancer; Environmental factors; MTHFR; Polymorphism; Thailand

Indexed keywords

METHYLENETETRAHYDROFOLATE REDUCTASE (NADPH2);

ADULT; ARTICLE; CASE CONTROL STUDY; COLON TUMOR; CONSTIPATION; DIET; DRINKING BEHAVIOR; ENVIRONMENT; FEMALE; GENETIC POLYMORPHISM; GENETIC PREDISPOSITION; GENETICS; GENOTYPE; HUMAN; MALE; MIDDLE AGED; POLYMERASE CHAIN REACTION; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; RISK FACTOR; STATISTICAL MODEL; STATISTICS; THAILAND;

ADULT; ALCOHOL DRINKING; CASE-CONTROL STUDIES; COLONIC NEOPLASMS; CONSTIPATION; DIET; ENVIRONMENT; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; LOGISTIC MODELS; MALE; METHYLENETETRAHYDROFOLATE REDUCTASE (NADPH2); MIDDLE AGED; POLYMERASE CHAIN REACTION; POLYMORPHISM, GENETIC; POLYMORPHISM, RESTRICTION FRAGMENT LENGTH; RISK FACTORS; THAILAND;

EID: 77954922598     PISSN: 09175040     EISSN: 13499092     Source Type: Journal    
DOI: 10.2188/jea.JE20090140     Document Type: Article

References (67)

1. Vatanasapt V, Martin N, Sriplung H, Chindavijak K, Sontipong S, Sriamporn H, et al. Cancer incidence in Thailand, 1988-1991. Cancer Epidemiol Biomarkers Prev. 1995;4:475-83.
2. Deerasamee S, Martin N, Sontipong S, Sriamporn S, Sriplung H, Srivatanakul P, et al. Cancer registration in Thailand. Asian Pac J Cancer Prev. 2001;2:79-84.
3. Sriplung H, Wiangnon S, Sontipong S, Sumitsawan Y, Martin N. Cancer incidence trends in Thailand, 1989-2000. Asian Pac J Cancer Prev. 2006;7:239-44.
4. Khuhaprema T, Srivatanakul P, Sriplung H, Wiangnon S, Sumitsawan Y, Attasara P. Cancer in Thailand, Vol. IV, 1998-2000 ed., vol. 4. Bangkok: Bangkok Medical Publisher; 2007.
5. Potter JD, McMichael AJ. Diet and cancer of the colon and rectum: a case-control study. J Natl Cancer Inst. 1986;76:557-69.
6. Potter JD, Slattery ML, Bostick RM, Gapsur SM. Colon cancer: review of the epidemiology. Epidemiol Rev. 1993;15:499-545.
7. Giovannucci E, Egan KM, Hunter DJ, Stampfer MJ, Colditz GA, Willett WC, et al. Aspirin and the risk of colorectal cancer in women. N Engl J Med. 1995;333:609-14.
8. Matsuo K, Ito H, Wakai K, Hirose K, Saito T, Suzuki T, et al. One-carbon metabolism related gene polymorphisms interact with alcohol drinking to inuence the risk of colorectal cancer in Japan. Carcinogenesis. 2005;26:2164-71.
9. Suwanrungruang K, Wiangnon S, Sriamporn S, Sookprasert A, Rangsrikajee D, Kamsa-Ard S, et al. Trends in incidences of stomach and colorectal cancer in Khon Kaen, Thailand 1985-2004. Asian Pac J Cancer Prev. 2006;7:623-6.
10. Sriamporn S, Wiangnon S, Suwanrungruang K, Rungsrikaji D, Sukprasert A, Thipsuntornsak N, et al. Risk factors for colorectal cancer in northeast Thailand: lifestyle related. Asian Pac J Cancer Prev. 2007;8:573-7.
11. Theodoratou E, Farrington SM, Tenesa A, McNeill G, Cetnarskyj R, Barnetson RA, et al. Dietary vitamin B6 intake and the risk of colorectal cancer. Cancer Epidemiol Biomarkers Prev. 2008;17:171-82.
12. Hermann S, Rohrmann S, Linseisen J. Lifestyle factors, obesity and the risk of colorectal adenomas in EPIC-Heidelberg. Cancer Causes Control. 2009;20:1397-408.
13. Omata F, Brown WR, Tokuda Y, Takahashi O, Fukui T, Ueno F, et al. Modiable risk factors for colorectal neoplasms and hyperplastic polyps. Intern Med. 2009;48:123-8.
14. van Duijnhoven FJ, Bueno-De-Mesquita HB, Ferrari P, Jenab M, Boshuizen HC, Ros MM, et al. Fruit, vegetables, and colorectal cancer risk: the European Prospective Investigation into Cancer and Nutrition. Am J Clin Nutr. 2009;89:1441-52.
15. Wei YS, Lu JC, Wang L, Lan P, Zhao HJ, Pan ZZ, et al. Risk factors for sporadic colorectal cancer in southern Chinese. World J Gastroenterol. 2009;15:2526-30.
16. Wu IC, Lee CH, Kuo CH, Kuo FC, Wu DC, Ko YC, et al. Consumption of cigarettes but not betel quid or alcohol increases colorectal cancer risk. J Formos Med Assoc. 2009;108:155-63.
17. Benito E, Obrador A, Stiggelbout A, Bosch FX, Mulet M, Munoz N, et al. A population-based case-control study of colorectal cancer in Majorca. I. Dietary factors. Int J Cancer. 1990;45:69-76.
18. Glynn SA, Albanes D, Pietinen P, Brown CC, Rautalahti M, Tangrea JA, et al. Colorectal cancer and folate status: a nested case-control study among male smokers. Cancer Epidemiol Biomarkers Prev. 1996;5:487-94.
19. Sharp L, Little J, Brockton NT, Cotton SC, Masson LF, Haites NE, et al. Polymorphisms in the methylenetetrahydrofolate reductase (MTHFR) gene, intakes of folate and related B vitamins and colorectal cancer: a case-control study in a population with relatively low folate intake. Br J Nutr. 2008;99:379-89.
20. Giovannucci E, Stampfer MJ, Colditz GA, Rimm EB, Trichopoulos D, Rosner BA, et al. Folate, methionine, and alcohol intake and risk of colorectal adenoma. J Natl Cancer Inst. 1993;85:875-84.
21. Slattery ML, Caan BJ, Potter JD, Berry TD, Coates A, Duncan D, et al. Dietary energy sources and colon cancer risk. Am J Epidemiol. 1997;145:199-210.
22. Choi SW, Mason JB. Folate status: effects on pathways of colorectal carcinogenesis. J Nutr. 2002;132:2413S-8S.
23. Frosst P, Blom HJ, Milos R, Goyette P, Sheppard CA, Matthews RG, et al. A candidate genetic risk factor for vascular disease: a common mutation in methylenetetrahydrofolate reductase. Nat Genet. 1995;10:111-3.
24. Weisberg I, Tran P, Christensen B, Sibani S, Rozen R. A second genetic polymorphism in methylenetetrahydrofolate reductase (MTHFR) associated with decreased enzyme activity. Mol Genet Metab. 1998;64:169-72.
25. Jacques PF, Bostom AG, Williams RR, Ellison RC, Eckfeldt JH, Rosenberg IH, et al. Relation between folate status, a common mutation in methylenetetrahydrofolate reductase, and plasma homocysteine concentrations. Circulation. 1996;93:7-9.
26. Ma J, Stampfer MJ, Hennekens CH, Frosst P, Selhub J, Horsford J, et al. Methylenetetrahydrofolate reductase polymorphism, plasma folate, homocysteine, and risk of myocardial infarction in US physicians. Circulation. 1996;94:2410-6.
27. Ma J, Stampfer MJ, Giovannucci E, Artigas C, Hunter DJ, Fuchs C, et al. Methylenetetrahydrofolate reductase polymorphism, dietary interactions, and risk of colorectal cancer. Cancer Res. 1997;57:1098-102.
28. Chen J, Giovannucci EL, Hunter DJ. MTHFR polymorphism, methyl-replete diets and the risk of colorectal carcinoma and adenoma among U.S. men and women: an example of gene-environment interactions in colorectal tumorigenesis. J Nutr. 1999;129:560S-4S.
29. Slattery ML, Potter JD, Samowitz W, Schaffer D, Leppert M. Methylenetetrahydrofolate reductase, diet, and risk of colon cancer. Cancer Epidemiol Biomarkers Prev. 1999;8:513-8.
30. Skibola CF, Smith MT, Kane E, Roman E, Rollinson S, Cartwright RA, et al. Polymorphisms in the methylene-tetrahydrofolate reductase gene are associated with susceptibility to acute leukemia in adults. Proc Natl Acad Sci USA. 1999;96:12810-5.
31. Esteller M, Garcia A, Martinez-Palones JM, Xercavins J, Reventos J. Germ line polymorphisms in cytochrome-P450 1A1 (C4887 CYP1A1) and methylenetetrahydrofolate reductase (MTHFR) genes and endometrial cancer susceptibility. Carcinogenesis. 1997;18:2307-11.
32. Piyathilake CJ, Macaluso M, Johanning GL, Whiteside M, Heimburger DC, Giuliano A. Methylenetetrahydrofolate reductase (MTHFR) polymorphism increases the risk of cervical intraepithelial neoplasia. Anticancer Res. 2000;20:1751-7.
33. Song C, Xing D, Tan W, Wei Q, Lin D. Methylene-tetrahydrofolate reductase polymorphisms increase risk of esophageal squamous cell carcinoma in a Chinese population. Cancer Res. 2001;61:3272-5.
34. Shen H, Xu Y, Zheng Y, Qian Y, Yu R, Qin Y, et al. Polymorphisms of 5,10-methylenetetrahydrofolate reductase and risk of gastric cancer in a Chinese population: a case-control study. Int J Cancer. 2001;95:332-6.
35. Lin J, Spitz MR, Wang Y, Schabath MB, Gorlov IP, Hernandez LM, et al. Polymorphisms of folate metabolic genes and susceptibility to bladder cancer: a case-control study. Carcinogenesis. 2004;25:1639-47.
36. Sriamporn S, Parkin DM, Pisani P, Vatanasapt V, Suwanrungruang K, Kamsa-ard P, et al. A prospective study of diet, lifestyle, and genetic factors and the risk of cancer in Khon Kaen Province, northeast Thailand: description of the cohort. Asian Pac J Cancer Prev. 2005;6:295-303.
37. En.wikipedia.org [homepage on the Internet]. Unit of alcohol London: Wikimedia Foundation, Inc., 2009.
38. Curado MP, Edwards B, Shin HR, Storm H, Ferlay J, Heanue M, et al. Cancer Incidence in Five Continents, Vol. IX. ed. Lyon: IARC Scientic Publications, International Agency for Research on Cancer; 2007.
39. Sonnenberg A, Muller AD. Constipation and cathartics as risk factors of colorectal cancer: a meta-analysis. Pharmacology. 1993;47 Suppl 1:224-33.
40. Burkitt DP. Epidemiology of cancer of the colon and rectum. Cancer. 1971;28:3-13.
41. Jacobs EJ, White E. Constipation, laxative use, and colon cancer among middle-aged adults. Epidemiology. 1998;9:385-91.
42. Narisawa T, Magadia NE, Weisburger JH, Wynder EL. Promoting effect of bile acids on colon carcinogenesis after intrarectal instillation of N-methyl-N′-nitro-N-nitrosoguanidine in rats. J Natl Cancer Inst. 1974;53:1093-7.
43. Reddy BS, Watanabe K, Weisburger JH, Wynder EL. Promoting effect of bile acids in colon carcinogenesis in germ-free and conventional F344 rats. Cancer Res. 1977;37:3238-42.
44. Clinton SK, Bostwick DG, Olson LM, Mangian HJ, Visek WJ. Effects of ammonium acetate and sodium cholate on N-methyl-N′-nitro-N-nitrosoguanidine-induced colon carcinogenesis of rats. Cancer Res. 1988;48:3035-9.
45. Zarkovic M, Qin X, Nakatsuru Y, Oda H, Nakamura T, Shamsuddin AM, et al. Tumor promotion by fecapentaene-12 in a rat colon carcinogenesis model. Carcinogenesis. 1993;14:1261-4.
46. Potter JD. Fiber and colorectal cancer-where to now? N Engl J Med. 1999;340:223-4.
47. Sriamporn S, Black RJ, Sankaranarayanan R, Kamsa-ad S, Parkin DM, Vatanasapt V. Cancer survival in Khon Kaen Province, Thailand. Int J Cancer. 1995;61:296-300.
48. Garro AJ, Lieber CS. Alcohol and cancer. Annu Rev Pharmacol Toxicol. 1990;30:219-49.
49. Steinmetz KA, Potter JD. Vegetables, fruit, and cancer prevention: a review. J Am Diet Assoc. 1996;96:1027-39.
50. Ulrich CM, Kampman E, Bigler J, Schwartz SM, Chen C, Bostick R, et al. Colorectal adenomas and the C677T MTHFR polymorphism: evidence for gene-environment interaction? Cancer Epidemiol Biomarkers Prev. 1999;8:659-68.
51. Keku T, Millikan R, Worley K, Winkel S, Eaton A, Biscocho L, et al. 5,10-Methylenetetrahydrofolate reductase codon 677 and 1298 polymorphisms and colon cancer in African Americans and whites. Cancer Epidemiol Biomarkers Prev. 2002;11:1611-21.
52. Boyapati SM, Bostick RM, McGlynn KA, Fina MF, Roufail WM, Geisinger KR, et al. Folate intake, MTHFR C677T polymorphism, alcohol consumption, and risk for sporadic colorectal adenoma (United States). Cancer Causes Control. 2004;15:493-501.
53. Yin G, Kono S, Toyomura K, Hagiwara T, Nagano J, Mizoue T, et al. Methylenetetrahydrofolate reductase C677T and A1298C polymorphisms and colorectal cancer: the Fukuoka Colorectal Cancer Study. Cancer Sci. 2004;95:908-13.
54. Jiang Q, Chen K, Ma X, Li Q, Yu W, Shu G, et al. Diets, polymorphisms of methylenetetrahydrofolate reductase, and the susceptibility of colon cancer and rectal cancer. Cancer Detect Prev. 2005;29:146-54.
55. Le Marchand L, Wilkens LR, Kolonel LN, Henderson BE. The MTHFR C677T polymorphism and colorectal cancer: the multiethnic cohort study. Cancer Epidemiol Biomarkers Prev. 2005;14:1198-203.
56. van den Donk M, Buijsse B, van den Berg SW, Ocke MC, Harryvan JL, Nagengast FM, et al. Dietary intake of folate and riboavin, MTHFR C677T genotype, and colorectal adenoma risk: a Dutch case-control study. Cancer Epidemiol Biomarkers Prev. 2005;14:1562-6.
57. Sohn KJ, Jang H, Campan M, Weisenberger DJ, Dickhout J, Wang YC, et al. The methylenetetrahydrofolate reductase C677T mutation induces cell-specic changes in genomic DNA methylation and uracil misincorporation: a possible molecular basis for the site-specic cancer risk modication. Int J Cancer. 2009;124:1999-2005.
58. Kim DH, Ahn YO, Lee BH, Tsuji E, Kiyohara C, Kono S. Methylenetetrahydrofolate reductase polymorphism, alcohol intake, and risks of colon and rectal cancers in Korea. Cancer Lett. 2004;216:199-205.
59. Wang J, Gajalakshmi V, Jiang J, Kuriki K, Suzuki S, Nagaya T, et al. Associations between 5,10-methylenetetrahydrofolate reductase codon 677 and 1298 genetic polymorphisms and environmental factors with reference to susceptibility to colorectal cancer: a case-control study in an Indian population. Int J Cancer. 2006;118:991-7.
60. Ueland PM, Hustad S, Schneede J, Refsum H, Vollset SE. Biological and clinical implications of the MTHFR C677T polymorphism. Trends Pharmacol Sci. 2001;22:195-201.
61. Kim YI. 5,10-Methylenetetrahydrofolate reductase polymorphisms and pharmacogenetics: a new role of single nucleotide polymorphisms in the folate metabolic pathway in human health and disease. Nutr Rev. 2005;63:398-407.
62. Houlston RS, Tomlinson IP. Polymorphisms and colorectal tumor risk. Gastroenterology. 2001;121:282-301.
63. de Jong MM, Nolte IM, te Meerman GJ, van der Graaf WT, de Vries EG, Sijmons RH, et al. Low-penetrance genes and their involvement in colorectal cancer susceptibility. Cancer Epidemiol Biomarkers Prev. 2002;11:1332-52.
64. Sharp L, Little J. Polymorphisms in genes involved in folate metabolism and colorectal neoplasia: a HuGE review. Am J Epidemiol. 2004;159:423-43.
65. Sibani S, Leclerc D, Weisberg II, Rozen R. The silent T1317C mutation of methylenetetrahydrofolate reductase should not interfere with MboII restriction isotyping of the reported A1298C mutation. Mol Genet Metab. 1999;68:512.
66. van der Molen EF, Arends GE, Nelen WL, van der Put NJ, Heil SG, Eskes TK, et al. A common mutation in the 5,10-methylenetetrahydrofolate reductase gene as a new risk factor for placental vasculopathy. Am J Obstet Gynecol. 2000;182:1258-63.
67. de Alvarenga MP, Pavarino-Bertelli EC, Goloni-Bertollo EM. Comparing techniques for the identication of the MTHFR A1298C polymorphism. J Biomol Tech. 2008;19:103-5.